Anixa Biosciences Inc
ANIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000715446
In the last 90 days, Anixa Biosciences Inc insiders filed 15 open-market purchases and 0 sales; 63 institutions reported holding it in 13F filings for Q2 2026, worth $15.0M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Anixa Biosciences Inc changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 29 | 32 | +3 |
| Shares | 2.51M | 2.95M | +439.6K (+17.5%) |
| Value | $11.8M | $11.5M | −$302.9K (−2.6%) |
New holders (8)
Institutions that held Anixa Biosciences Inc at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 124,499 | $483.0K | 0.00% |
| Two Sigma Investments, LP | 52,450 | $204.0K | 0.00% |
| State Street Corp | 23,287 | $90.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 19,979 | $77.0K | 0.00% |
| Susquehanna International Group, LLP | 16,906 | $66.0K | 0.00% |
| Ameriprise Financial Inc | 10,400 | $40.0K | 0.00% |
| Advisory Services Network, LLC | 400 | $2.00K | 0.00% |
| Global Retirement Partners, LLC | 180 | $1.00K | 0.00% |
Sold out (5)
Institutions that held Anixa Biosciences Inc at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Jane Street Group, LLC | 26,093 | $122.0K |
| Wealth Alliance Advisory Group, LLC | 20,100 | $94.0K |
| Citadel Advisors LLC | 19,682 | $92.0K |
| Qube Research & Technologies Ltd | 13,293 | $62.0K |
| Dorsey Wright & Associates | 8,093 | $37.9K |